Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Dabigatran [1] Dabigatran[1] Dabigatran 💬 [1] F2 💬 [8] Complement and coagulation cascades, Coronavirus disease, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬[5] 51, 75, 85, 91, 124 💬
2 Gold [1] Gold---[71] 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
3 Rivaroxaban [1] Rivaroxaban[1] Rivaroxaban 💬 [1] F10 💬 [1] Complement and coagulation cascades 💬[10] 46, 48, 49, 56, 58, 75, 91, 210, 222, 271 💬
4 Warfarin [3] Warfarin; Warfarin Potassium; Warfarin Sodium[3] Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬
[2] NQO1,
VKORC1 💬
[5] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[15] 6, 8, 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬